Analysis of parameters affecting engraftment in children undergoing autologous peripheral blood stem cell transplants

Bone Marrow Transplantation

Volumn 25, Issue 6, 2000, Pages 583-588

  Figuerres, E ^a   Haut, P R ^b   Olzewski, M ^b   Kletzel, M ^b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Engraftment; PBSC; Pediatrics; Transplant

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CARBOPLATIN; CD34 ANTIGEN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; THIOTEPA; VINBLASTINE SULFATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; BURKITT LYMPHOMA; BURST FORMING UNIT E; CELL NUCLEUS; CHILD; CLINICAL TRIAL; COLONY FORMING UNIT GM; EWING SARCOMA; GERM CELL TUMOR; GLIOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOBLASTOMA; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MONONUCLEAR CELL; NEPHROBLASTOMA; NEUROBLASTOMA; NEUTROPHIL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; STATISTICAL ANALYSIS; THROMBOCYTE;

EID: 0034114816     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702193     Document Type: Article

References (24)

1. Kessigner A, Armitage JO, Smither DM et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1260-1265.
2. To LB, Roberts MM, Haylock D et al. Comparison of haematological recovery time and supportive care requirements of autologous peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
3. Hill RS, Mazza P, Amos D. Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation. Bone Marrow Transplant 1989; 4: 69-74.
4. To LB, Dyson PG, Branford AL. Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous haemopoietic reconstitution in acute non-lymphoblastic leukemia. Bone Marrow Transplant 1987; 2: 103-108.
5. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 1992; 1: 640-644.
6. Henon PR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1993; 9: 285-291.
7. Schwarzberg L, Birch R, Blanco R et al. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 1993; 11: 369-374.
8. To LB, Dyson PG, Branford AL et al. CFU-mix are no better than CFU-GM in predicting hemopoietic reconstitutive capacity of peripheral blood stem cell collected in the very early remission phase of acute nonlymphoblastic leukemia. Exp Hematol 1987; 15: 351-354.
9. Kawano Y, Takaue Y, Watanabe T et al. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children. Exp Hematol 1993; 21: 103-108.
10. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stern cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21: 508-514.
11. Brice P, Marolleau JP, Dompret H et al. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas. Bone Marrow Transplant 1992; 9: 285-291.
12. Elias AD, Ayash L, Anderson KC et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992; 79: 3036-3044.
13. Besinger WI, Longin K, Appelbaum S et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
14. Fritsch G, Emminger W, Buchinger P et al. CD34 positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp Hematol 1991; 19: 1079-1083.
15. Weaver CH, Hazelton B, Birch RI et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 10: 3961-3969.
16. Sutherland JH, Eaves CJ, Lansdorp PM et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808-3814.
17. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
18. Hazelton B, Birch R, Schwartzberg L et al. CD34 yield alone is sufficient to determine adequacy of peripheral blood progenitor cell products. Proc Am Assoc Cancer Res 1994; 35: 205-212.
19. + cell dose in engraftment kinetics. Bone Marrow Transplant 1996; 18: 699-703.
20. Brodeur GM, Seeger RC, Barret A et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988; 6: 1874-1881.
21. Cohn S, Moss TJ, Hoover M et al. Treatment of poor risk neuroblastoma patients with high dose chemotherapy and autologous peripheral stem cell rescue. Bone Marrow Transplant 1997; 20: 543-551.
22. Rowley SD. Hematopoietic progenitor cell assay. In: Areman E, Deeg HJ, Sacher RA (eds). Bone Marrow Stem Cell Processing: A Manual of Current Techniques. FA Davis: Philadelphia, 1992, p 406.
23. Henon PH. Blood stem cell autografts in malignant blood diseases. The French experience with a special focus on myeloma. Haematologica 1990; 751: 53-59.
24. Henon PR, Butturini A, Gale RP. Blood-derived haematopoietic cell transplants: blood to blood? Lancet 1991; 337: 961-963.